Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials; Draft Guidance for Industry; Availability
NonrulemakingNoticeFDA_FRDOC_0001-14302
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 24, 2026
- Agency
- Food and Drug Administration (FDA)
